Cargando…

Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19

The trajectory from moderate and severe COVID-19 into acute respiratory distress syndrome (ARDS) necessitating mechanical ventilation (MV) is a field of active research. We determined serum levels within 24 h of presentation of 20 different sets of mediators (calprotectin, pro- and anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kassianidis, Georgios, Siampanos, Athanasios, Poulakou, Garyphalia, Adamis, George, Rapti, Aggeliki, Milionis, Haralampos, Dalekos, George N., Petrakis, Vasileios, Sympardi, Styliani, Metallidis, Symeon, Alexiou, Zoi, Gkavogianni, Theologia, Giamarellos-Bourboulis, Evangelos J., Theoharides, Theoharis C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099708/ https://www.ncbi.nlm.nih.gov/pubmed/35563282 http://dx.doi.org/10.3390/ijms23094894

Ejemplares similares

Staphylococcus Aureus Osteomyelitis as an Inducer of Tolerance to Escherichia Coli Pyelonephritis: an Experimental Study
por: Goumenos, Stavros, et al.
Publicado: (2020)

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia
por: Samaras, Charilaos, et al.
Publicado: (2023)

Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial
por: Tsiakos, Konstantinos, et al.
Publicado: (2021)

Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
por: Sagris, Dimitrios, et al.
Publicado: (2021)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2022)

Monkeypox: A real new warning or just a sign of times?
por: Georgiadou, Sara P., et al.
Publicado: (2023)

Understanding resistance in Pseudomonas
por: Dimopoulos, George, et al.
Publicado: (2020)

Does leukocyte apoptosis play any role in the pathogenesis of experimental pancreatitis?
por: Zotos, D, et al.
Publicado: (2011)

Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk
por: Tsilika, Maria, et al.
Publicado: (2022)

ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk
por: Tsilika, Maria, et al.
Publicado: (2022)

IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19
por: Renieris, Georgios, et al.
Publicado: (2022)

Bacterial load plays a crucial role for survival in experimental peritonitis and modulates immunoparalysis of monocytes
por: Atmatzidis, S, et al.
Publicado: (2010)

Acute Brucellosis and Cirrhosis: The Triggering Event of Fatal Liver Decompensation
por: Kosmidou, Maria, et al.
Publicado: (2020)

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

IFNγ prolongs survival in experimental Escherichia coli pyelonephritis: implications for favorable phagocytosis
por: Katsaris, M, et al.
Publicado: (2011)

Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report
por: Dimopoulos, George, et al.
Publicado: (2010)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

Potential association of mast cells with coronavirus disease 2019
por: Theoharides, Theoharis C.
Publicado: (2021)

Stress, Inflammation, and Autoimmunity: The 3 Modern Erinyes
por: Theoharides, Theoharis C.
Publicado: (2020)

Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder
por: Theoharides, Theoharis C.
Publicado: (2021)

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
por: Theoharides, Theoharis C.
Publicado: (2022)

The Role of Mast Cells and Their Inflammatory Mediators in Immunity
por: Theoharides, Theoharis C.
Publicado: (2023)

Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
por: Galani, Irene, et al.
Publicado: (2012)

Trichinosis Imitating an Inflammatory Systematic Disease
por: Kosmidou, Maria, et al.
Publicado: (2021)

A review of drug-induced hypernatraemia
por: Liamis, George, et al.
Publicado: (2009)

Neuro-inflammation, blood-brain barrier, seizures and autism
por: Theoharides, Theoharis C, et al.
Publicado: (2011)

Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin
por: Asadi, Shahrzad, et al.
Publicado: (2012)

Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β
por: Tsilioni, Irene, et al.
Publicado: (2018)

Effect of stress on learning and motivation-relevance to autism spectrum disorder
por: Theoharides, Theoharis C, et al.
Publicado: (2019)

IgE and macrophages for cancer rescue?
por: Conti, Pio, et al.
Publicado: (2019)

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
por: Theoharides, Theoharis C., et al.
Publicado: (2023)

Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33
por: Tsilioni, Irene, et al.
Publicado: (2023)

Potential Role of Moesin in Regulating Mast Cell Secretion
por: Theoharides, Theoharis C., et al.
Publicado: (2023)

Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity
por: Printza, Athanasia, et al.
Publicado: (2021)

The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2021)

Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lq4uv6v9ikaaortm79srlpp9go